Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Tilray Brands, Inc. (TLRY)

$3.88 -2.76% NASDAQ: TLRY · 15-min delayed
  • NEW YORK, New York
  • Public · NASDAQ: TLRY
  • 2,842 employees
$590.8MMarket cap
$821.3MRevenue · FY2025
-$2.2BNet income
2,842Employees
TLRYNASDAQ
2015IPO

About Tilray Brands, Inc.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$821.3M
Net income
-$2.2B
Total assets
$2.1B
Market cap
$590.8M
Gross margin
29.3%
Operating margin
-277.9%
Net margin
-265.6%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$821.3M
Cost of revenue
$580.7M
Gross profit
$240.6M
Operating expenses
$2.5B
Operating income
-$2.3B
Income tax
-$121.0M
Net income
-$2.2B
EPS (basic)
$-2.46
EPS (diluted)
$-2.46

Balance sheet

Total assets
$2.1B
Current assets
$688.6M
Total liabilities
$584.8M
Current liabilities
$280.3M
Shareholders’ equity
$1.5B

Cash flow

Operating cash flow
-$94.6M
Investing cash flow
-$46.7M
Financing cash flow
$133.5M
Net cash flow
-$6.7M

Statements via Polygon.io (SEC filings)

NASDAQ: TLRY
$3.88 -2.76%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.60 $21.00

52-week range

Market cap
$590.8M
EPS (diluted)
$-2.46
Shares outstanding
152.3M
Open
Day range
Prev close
Volume
IPO date
Jan 23, 2015

Tilray Brands, Inc. (TLRY) Stock Price

  • Reported a net loss of $2.2B in FY2025.
  • Revenue grew 60% from FY2021 to FY2025.
  • Gross margin of 29.3%, net margin -265.6%.
  • Trading 82% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Tilray Brands, Inc..

Write a review
Newsroom

News about Tilray Brands, Inc.

News & sentiment via Polygon.io

FAQ

Tilray Brands, Inc.: frequently asked questions

Is Tilray Brands, Inc. an American company?

Tilray Brands, Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Tilray Brands, Inc. headquartered?

Tilray Brands, Inc. is headquartered in New York, New York, United States.

Is Tilray Brands, Inc. publicly traded?

Yes — Tilray Brands, Inc. is a publicly traded company. Its stock trades under the ticker symbol TLRY on the NASDAQ.

What does Tilray Brands, Inc. do?

Tilray Brands, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →